Medicare Enrolled

Dr. Tony Luongo, MD

Urology Physician · Boston, MA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
800 WASHINGTON ST, Boston, MA 02111
6176365000
In practice since 2006 (19 years)
NPI: 1164520417 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Luongo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Luongo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Luongo

Dr. Tony Luongo is an urology physician in Boston, MA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Luongo performed 567 Medicare services across 482 unique beneficiaries.

Between the years covered by Open Payments, Dr. Luongo received a total of $440,459 from 54 pharmaceutical and/or device companies across 511 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Luongo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 567 Medicare services $440,459 industry payments

Medicare Practice Summary

Medicare Utilization ↗
567
Medicare services
Bottom 23% in MA for urology physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
482
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~30 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
107 $3 $9
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
64 $76 $269
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
56 $108 $381
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
38 $42 $113
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
35 $63 $213
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
31 $139 $490
Simple insertion of temporary bladder tube
A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder.
28 $19 $197
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
28 $157 $530
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
24 $105 $762
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
24 $28 $554
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
23 $139 $1,592
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
21 $216 $731
Initial hospital admission, low complexity
Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter.
19 $72 $292
New patient office visit, complex (60-74 min) 16 $171 $646
Bladder irrigation and/or instillation
This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder.
15 $21 $243
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
13 $10 $44
Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm
This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters.
13 $245 $843
Endoscopic removal of foreign body, stone, or stent from urethra or bladder
A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item.
12 $129 $958
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.2% high complexity
10.8% medium
83.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$440,459
Total received (2018-2024)
Avg $62,923/year across 7 years
Top 1% in MA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
511
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$337,111 (76.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$100,972 (22.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,377 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$41,667
2023
$9,698
2022
$30,416
2021
$38,393
2020
$36,979
2019
$88,388
2018
$194,919

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$34,980
Medtronic, Inc.
$4,500
Astellas Pharma US Inc
$882
Ambu A/S
$750
Ferring Pharmaceuticals Inc.
$129
Merck Sharp & Dohme LLC
$104
180 Medical, Inc.
$84
IMMUNITYBIO, INC.
$63
ConvaTec Inc.
$49
C. R. Bard, Inc. & Subsidiaries
$40
Teleflex LLC
$37
Tolmar, Inc.
$27
Telix Pharmaceuticals
$22
Top 3 companies account for 96.9% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Scientific Affairs, LLC
$127,890
Astellas Pharma US Inc
$123,544
Janssen Biotech, Inc.
$98,064
PFIZER INC.
$45,954
Medtronic, Inc.
$10,634
Myovant Sciences Inc.
$10,616
BARD PERIPHERAL VASCULAR, INC.
$4,950
C. R. BARD, INC. & SUBSIDIARIES
$4,295
Lutonix, Inc.
$4,150
Bayer HealthCare Pharmaceuticals Inc.
$1,841
Olympus Medical Systems Corporation
$1,620
C. R. Bard, Inc. & Subsidiaries
$1,425
Ambu A/S
$750
Gyrus ACMI, Inc.
$550
SUN PHARMACEUTICAL INDUSTRIES INC.
$500
TerSera Therapeutics LLC
$487
Bard Peripheral Vascular, Inc.
$400
GENZYME CORPORATION
$350
Rochester Medical Corporation
$285
TOLMAR Pharmaceuticals, Inc.
$188
180 Medical, Inc.
$138
Ferring Pharmaceuticals Inc.
$129
Amgen Inc.
$125
UroGen Pharma, Inc.
$121
Antares Pharma, Inc.
$112
Boston Scientific Corporation
$106
Merck Sharp & Dohme LLC
$104
Blue Earth Diagnostics Limited
$94
Progenics Pharmaceuticals, Inc.
$83
AbbVie, Inc.
$64
IMMUNITYBIO, INC.
$63
Amniox Medical, Inc.
$58
NeoTract Inc.
$57
ABBVIE INC.
$55
MEDIVATION FIELD SOLUTIONS LLC
$53
Coloplast Corp
$50
ConvaTec Inc.
$49
Telix Pharmaceuticals
$46
Avadel Specialty Pharmaceuticals, LLC
$44
Ethicon US, LLC
$43
UROVANT SCIENCES INC
$43
Endo Pharmaceuticals Inc.
$41
Intuitive Surgical, Inc.
$40
Sumitomo Pharma America, Inc.
$38
Teleflex LLC
$37
Photocure Inc
$29
Tolmar, Inc.
$27
Metuchen Pharmaceuticals
$20
UROGEN PHARMA, INC.
$19
Allergan Inc.
$17
Medtronic USA, Inc.
$15
Myriad Genetic Laboratories, Inc.
$15
EDAP TECHNOMED INC
$15
NxThera, Inc.
$14
Top 3 companies account for 79.3% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AMS · ANKTIVA · AVEED · Axumin · BOTOX · Bard Urinary Drainage Bag · Cysview · Da Vinci Surgical System · ECHELON FLEX Stapler · ELIGARD · ERLEADA · Erleada · GEMTESA · GENTLECATH · GENTLECATH GLIDE · ILLUCCIX · INTERSTIM · JELMYTO · JEVTANA · KEYTRUDA · LUTONIX · LYNPARZA · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · Myrbetriq · NEOX · NOCDURNA · Noctiva · Non-Covered · OES CHOLEDOCHOFIBERSCOPE · ORGOVYX · PYLARIFY · Prolaris · Prolia · Rezum · Rezum Generator · SPEEDICATH · SURGICEL Family of Absorbable Hemostats · Stendra · TOVIAZ · UROLIFT · UroLift · XIAFLEX · XTANDI · XYOSTED · Xtandi · YONSA · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for urology physician in MA.

Looking for an urology physician in Boston?
Compare urology physicians in the Boston area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
219
Per 100K population
28.0
County median income
$92,859
Nearest hospital
TUFTS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Luongo is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of MA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Luongo experienced with urinalysis, manual?
Based on Medicare claims data, Dr. Luongo performed 107 urinalysis, manual services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Luongo receive payments from pharmaceutical companies?
Yes. Dr. Luongo received a total of $440,459 from 54 companies across 511 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Luongo's costs compare to other urology physicians in Boston?
Dr. Luongo's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Luongo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →